TA on Cleveland Biolabs. This company is currently finalizing a merger agreement. Expect a lot of movement in the coming months. Looking at the July options, it appears something will be announced in June or early July. Price movement should be around 6x out of this. Company is leading in the treatment of ARS (acute radiation syndrome). Great add to the portfolio for some near term returns.
As always, please let me know if you see something I didn't catch.
Anche su:
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.